Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More
Xconomy
MAY 10, 2019
The market for drugs for rare or “orphan” diseases continues to grow. The field has gotten so competitive that multiple products are on the market for some diseases. Patients with the rare, debilitating transthyretin amyloidosis had no marketed. Soon there could be three.
Let's personalize your content